Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
When people like you miss out, then it becomes a scam.... Find something better to do this morning than watch the market.
This is the scam that the penny promo. use so they can buy in before open drive it up make there money and dump it on the people who fall into there trap. And then they say they predicted whatever price it goes to.
well good for u, I don't get insider info, I still have to do DD and the first thing u see is a an A/S increase from 350 mil to 500 mil big RED flag newbies gotta learn to read b4 jumping
I bought weeks ago on the early alert! Told to hold for the pump and boom sold to some poor bag holder! Muuuuuuuhahahahah. Going to be $0.0001 soon. We all told to short now! Muuuuuuhahahahahaha
if this co. really had anything u think these guyz are the only one who knew, this board was dead for a reason, look for .01 by Monday
those who bought are doomed! muuuuuhahahaha
thank you for buying my shares and holding that bag of poo! muuuuuuuhahahahaha
I sold at opening bell! Muuuuuhahahahaha
YES IF YOU GOT IN TODAY IT MIGHT BE TOO LATE IMO
CONGRATS TO THOSE WHO WHERE IN EARLIER!!
No r/s, really +1000% today?
Great if you're an insider. From .007 to .15 in less than a second at opening bell.
Stock Psycho (Darth Trader) Picks almost always play this way IMHO.
He and his buddies get their orders set before open, then they drive it up and dump it. Typical play lasts 30 minutes. Every so once in a while, he gets it right for a multi-day, but these days - rarely.
Can't wait to hear how great he did but "something" happened that "I didn't like" all the same ol crap while he and his crewe are counting the haul from their pinky heist.
I can't believe people still fall for the pumper crap day after day.
This sh*& should be illegal! Robbery. I feel sorry for whoever bought this morning!
Anyone who got in today is gonna be a loser from the looks of it.
Like always they over-gapped the open to make sure nobody else makes money.
GNLK just increased A/S by 150mil guess they gonna try to sell them all today, read b4 u buy here To approve and adopt an amendment to the Company’s Articles of Incorporation to increase the Company’s capitalization from 350,000,000 shares of Common Stock, $0.01 par value, to 500,000,000 shares of Common Stock, $0.01 par value
Another Darth Trader PUMP and this board didn't even know about it. His insiders got in before the open as usual and drove the price up nearly 2000%. Buy now and wait to get dumped on.
Capsalus Corp. Completes Purchase Of GeneLink Biosciences, Inc's GeneWize Life Sciences, Inc.
Capsalus Corp. announced that it has completed the acquisition of the stock of GeneWize Life Sciences, Inc., the wholly-owned direct-selling subsidiary of GeneLink Biosciences, Inc. The deal will provide immediate revenues. Noteworthy participants in this transaction included Fidelity Holdings, Inc., Wharton Equity Partners, and Gene Elite, LLC, a private investor consortium. With their collective involvement, Capsalus plans to bring not only financial support to GeneWize, but also hands-on operational and strategic development opportunities. Terms of the transaction were not disclosed. Full Article
http://www.reuters.com/finance/stocks/GNLK.OB/key-developments
GNLK SEC Filings -
http://finance.yahoo.com/q/sec?s=GNLK.OB+SEC+Filings
Yahoo GNLK Financials -
http://finance.yahoo.com/q/is?s=gnlk.ob
GeneLink BioSciences, Inc. Ranked Number 33 Fastest Growing Company in North America on Deloitte’s 2011 Technology Fast 500
Attributes its 4,363 Percent Revenue Growth to its Leadership Position in Consumer Genetics
Orlando, Florida – October 24, 2011 – GeneLink BioSciences, Inc. (OTC Bulletin Board: GNLK), a leading consumer genomics biotech company, today announced that it ranked number 33 on Technology Fast 500TM, Deloitte’s ranking of 500 of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. GeneLink grew 4,363 percent during the period 2006-2010.
Genelink’s chief executive officer, Dr. Bernard L. Kasten, Jr., credits the Company’s leading genetic science and its proprietary genetic assessments and personalized health products for the Company’s dramatic revenue growth. Dr. Kasten said, “We are proud that Deloitte has recognized our remarkable growth for the third consecutive year. We at GeneLink have spent the current year developing and formalizing additional marketing relationships, some of which have been announced, and enhancing our scientific resources, manufacturing capabilities and infrastructure, which we anticipate will enable us to sustain this impressive rate of growth.”
“GeneLink, like all 2011 Technology Fast 500TM companies, has excelled in fostering innovation and channeling it into spectacular growth – against the backdrop of one of the most challenging economies in history,” said Eric Openshaw, vice chairman and U.S. technology, media and telecommunications leader. Deloitte L.P. “Deloitte commends GeneLink for this remarkable accomplishment.”
“We are pleased to honor GeneLink as a 2011 Technology Fast 500 company,” said Mark Jensen, managing partner, technology and venture capital services, Deloitte & Touch LLP. “As one of the fastest growing tech companies in North America, GeneLink has demonstrated excellence in technological innovation, entrepreneurship and rapid growth.”
GeneLink previously ranked number 92 as a Technology Fast 500TM award winner for 2008 and number 66 for 2009.
About Deloitte’s 2011 Technology Fast 500TM
Technology Fast 500, which was conducted by Deloitte & Touche, LLP, a subsidiary of Deloitte LLP, provides a ranking of the fastest growing technology, media, telecommunications, life sciences and clean technology companies – both public and private – in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2006 to 2010.
In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company’s operating revenues. Companies must have base-year operating revenues of at least $50,000 USD or CD, and current-year operating revenues of at least $5 million USD or CD. Additionally, companies must be in business for a minimum of five years,and be headquartered within North America.
About GeneLink BioSciences, Inc.:
GeneLink Biosciences, Inc. (www.genelinkbio.com) is a 17-year old leading biosciences company specializing in consumer genomics. GeneLink’s patented technologies include proprietary DNA test
assessments linked to personalized health, beauty and wellness applications and products. Its DNA assessments provide information that enables the customization of nutritional and skincare products designed and manufactured to fulfill each individual consumer’s wellness needs.
This release contains certain forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. With the
exception of historical information contained herein, the matters discussed in the press release involve risk and uncertainties. Actual results could differ materially from those expressed in any forward-looking statement. GeneLink disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future developments or otherwise.
Contact:
GeneLink Biosciences, Inc.
Bernard L. Kasten, Jr. , M.D., Chairman and CEO
Tel: 800-558-4363
Genelink Investor Relations:
Tel: 407-772-7164
Email: IR@genelinkbio.com
http://genelinkbio.com/2011/11/08/fastest-growing-company/
GENELINK BIOSCIENCES AGREES TO SELL GENEWIZE LIFE SCIENCES
Will Continue to Supply DNA-Customized Products to Former Subsidiary
ORLANDO, FL – Oct. 13, 2011 – GeneLink Biosciences, Inc. (OTCBB:GNLK), a leading consumer genomics biotech company, has finalized a definitive agreement with Capsalus Corp. (OTCBB:WELL), a public company operating in the health and wellness space, to sell the stock of its wholly owned direct-selling subsidiary GeneWize Life Sciences, Inc., pending GeneLink shareholder approval and other related terms. The deal enables GeneLink to leverage the strengths of its sales and marketing partners to accelerate its growth strategy and to focus on the company’s core competencies. GeneLink holds a leadership position in consumer genomics, combining genetic science, wellness and customization to create innovative consumer products, including skincare and nutritional supplements. Through its operation of GeneWize, GeneLink generated more than $25 million in revenues over the past three years, demonstrating the commercial viability of its DNA-customized products.
The divestiture of GeneWize marks a major milestone in GeneLink’s plans to focus the business around the company’s core competencies and outsource sales and marketing to established players in discrete channels, including GeneWize, which will continue to market and distribute GeneLink products. This transaction will allow GeneLink to concentrate on further enhancing the company’s offerings by investing in research and development of genetic test panels and customized products based on GeneLink’s proprietary DNA assessments.
“We’re optimistic about this next stage of rapid expansion in our company’s development lifecycle,” said Bernard L. Kasten Jr., M.D., GeneLink’s Chairman and CEO. “With this deal, we will be well capitalized to build out our manufacturing and fulfillment infrastructure thereby increasing capacity, driving economies of scale and lowering our cost of goods. As it relates to distribution partners like GeneWize, we expect that the opportunities for increased sales and margin enhancement will drive GeneLink towards profitability.”
GeneLink Biosciences, Inc. (www.genelinkbio.com) is a 17-year old leading biosciences company specializing in consumer genomics. GeneLink’s patented technologies include proprietary DNA test assessments linked to personalized health, beauty and wellness applications and products. Its DNA assessments provide information that enables the customization of nutritional and skincare products designed and manufactured to fulfill each individual consumer’s wellness needs.
Forward-looking Statements
This news release may contain “Forward-looking Statements” within the meaning of Section 21E of the United States Securities Exchange Act, as amended. All statements in this news release, other than statements of historical fact, are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. This notice expressly qualifies all forward-looking statements in this news release.
Contact:
GeneLink Biosciences, Inc.
Bernard L. Kasten, Jr. , M.D., Chairman and CEO
Tel: 800-558-4363
Genelink Investor Relations:
Tel: 407-772-7164
Email: IR@genelinkbio.com
http://genelinkbio.com/2011/11/08/genelink-biosciences-agrees-to-sell-genewize-life-sciences/
Looks like the CEO purchased over a mill shares at 8 cents. That's encouraging for something promising to come.
GeneWize News Jan.2011 - http://www.gwnewscast.com/2011/january/013111.shtml
Nice move. One of the few real companies down in the gutter in otc land. Gonna see where this move takes us over the next week then find a dip. They took this up to .55c after the market crash. Could have some legs in here
Good to have you on board
You sold me or actually I agree
I bought some, the Tempur guy and his friends will add street cred and marketing skills. All pennies are a gamble but I think its a good company move for GNLK.
WE hired TEMPURPEDICS FIRST CEO this guy knows how to market and sell
http://ih.advfn.com/p.php?pid=nmona&article=46008276&symbol=TPX
TO DA MOON
why is this dropping ? anyone read the 3Q statement ?
GNLK - Financial Reports -
http://www.otcmarkets.com/stock/GNLK/financials
GNLK - OTC Pink Sheets Level II -
http://www.otcmarkets.com/stock/GNLK/quote
GeneWize Weekly News - http://www.gwnewscast.com/
This is a gem! Longs will be rewarded.
eom
any thoughts on this stock option thing the Genewize subsidiary is doing ? help? or not ?
well someone is getting some great buys and stocking up. Lets hope the new management can figgure out a way to market the GREAT technologies they have to make this company some money so the stock value goes to where it should be .
Some days we get a bit of volume but no significant price increase . Whats up with that ? People getting bored with holding or the acumulators trying to hold it down ? how thin is the L2 ask?
Time for shopping.
The price is good. I will try to load!
Not much selling going on. Almost positive bottom is in. IMO
partiall fill...so far
well in that case my friend.. congrats on the .115 snag.. :~)
lol...if peeps are selling, well I,m bidding....and getting some...not a momo stock..patience
Although I dont see your buys??
This is def a good spot. I am so amazed that peeps havnt caught on to this stock. Such a steal at this pps. I am perplexed!
Followers
|
20
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
573
|
Created
|
01/14/05
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |